Lazarus's gate: Challenges and potential of epigenetic reprogramming of somatic cells

Clinical Pharmacology and Therapeutics

Volumn 83, Issue 6, 2008, Pages 889-893

  Henderson, J T ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINEAGE; CELL NUCLEUS TRANSPLANTATION; CELL THERAPY; EPIGENETICS; GENE THERAPY; HUMAN; MEDICAL ETHICS; NONHUMAN; OOCYTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SAFETY; SOMATIC CELL; STEM CELL; ZYGOTE;

ANIMALS; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; FEMALE; HUMANS; NUCLEAR REPROGRAMMING; NUCLEAR TRANSFER TECHNIQUES; OOCYTES;

EID: 43949122956     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2008.51     Document Type: Review

References (32)

1. Krause, D.S. et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105, 369-377 (2001).
2. Zwaginga, J.J. & Doevendans, P. Stem cell-derived angiogenic/vasculogenic cells: possible therapies for tissue repair and tissue engineering. Clin. Exp. Pharmacol. Physiol. 30, 900-908 (2003).
3. Campbell, K.H. et al. Somatic cell nuclear transfer: past, present and future perspectives. Theriogenology 68 (suppl. 1), S214-S231 (2007).
4. Collas, P. & Taranger, C.K. Epigenetic reprogramming of nuclei using cell extracts. Stem Cell Rev. 2, 309-317 (2006).
5. Tada, M., Tada, T., Lefebvre, L., Barton, S.C. & Surani, M.A. Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J. 16, 6510-6520 (1997).
6. Campbell, K.H., McWhir, J., Ritchie, W.A. & Wilmut, I. Sheep cloned by nuclear transfer from a cultured cell line. Nature 380, 64-66 (1996).
7. Cibelli, J.B. et al. Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science 280, 1256-1258 (1998).
8. Meng, L., Ely, J.J., Stouffer, R.L. & Wolf, D.P. Rhesus monkeys produced by nuclear transfer. Biol. Reprod. 57, 454-459 (1997).
9. Onishi, A. et al. Pig cloning by microinjection of fetal fibroblast nuclei. Science 289, 1188-1190 (2000).
10. Baguisi, A. et al. Production of goats by somatic cell nuclear transfer. Nat. Biotechnol. 17, 456-461 (1999).
11. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
12. Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317 (2007).
13. Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324 (2007).
14. Tanaka, M., Hadjantonakis, A.K. & Nagy, A. Aggregation chimeras. Combining ES cells, diploid and tetraploid embryos. Methods Mol. Biol. 158, 135-154 (2001).
15. Meissner, A., Wernig, M. & Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25, 1177-1181 (2007).
16. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
17. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
18. White, J. & Dalton, S. Cell cycle control of embryonic stem cells. Stem Cell Rev. 1, 131-138 (2005).
19. Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106 (2007).
20. Clayton, E., Doupé, D.P., Klein, A.M., Winton, D.J., Simons, B.D. & Jones, P.H. A single type of progenitor cell maintains normal epidermis. Nature 446, 185-189 (2007).
21. Hanna, J. et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923 (2007).
22. Ertl, H.C. Challenges of immune responses in gene replacement therapy. IDrugs 8, 736-738 (2005).
23. Wu, X. & Burgess, S.M. Integration target site selection for retroviruses and transposable elements. Cell Mol. Life Sci. 61, 2588-2596 (2004).
24. Misra, R.P. & Duncan, S.A. Gene targeting in the mouse: advances in introduction of transgenes into the genome by homologous recombination. Endocrine 19, 229-238 (2002).
25. Little, M., Hall, W. & Orlandi, A. Delivering on the promise of human stem-cell research. What are the real barriers? EMBO Rep. 7, 1188-1192 (2006).
26. Caulfield, T., Ogbogu, U. & Isasi, R.M. Informed consent in embryonic stem cell research: are we following basic principles? CMAJ 176, 1722-1725 (2007).
27. Karpowicz, P., Cohen, C.B. & van der Kooy, D. It is ethical to transplant human stem cells into nonhuman embryos. Nat. Med. 10, 331-335 (2004).
28. Animal-human hybrid-embryo research. Lancet 370, 909 (2007).
29. Daley, G.Q. et al. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science 315, 603-604 (2007).
30. Mimeault, M., Hauke, R. & Batra, S.K. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin. Pharmacol. Ther. 82, 252-264 (2007).
31. Zandstra, P.W., Le, H.V., Daley, G.Q., Griffith, L.G. & Lauffenburger, D.A. Leukemia inhibitory factor (LIF) concentration modulates embryonic stem cell self-renewal and differentiation independently of proliferation. Biotechnol. Bioeng. 69, 607-617 (2000).
32. Chen, R., Cohen, L.G. & Hallett, M. Nervous system reorganization following injury. Neuroscience 111, 761-773 (2002).